GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » EPS (Basic)

J.Molner AS (OTSE:MOLNR) EPS (Basic) : €-0.68 (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS EPS (Basic)?

J.Molner AS's basic earnings per share (Basic EPS) for the six months ended in Dec. 2023 was €-0.40. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.68.

J.Molner AS's EPS (Diluted) for the six months ended in Dec. 2023 was €-0.40. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.68.

J.Molner AS's EPS without NRI for the six months ended in Dec. 2023 was €-0.40. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was -0.68.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


J.Molner AS EPS (Basic) Historical Data

The historical data trend for J.Molner AS's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS EPS (Basic) Chart

J.Molner AS Annual Data
Trend Dec21 Dec22 Dec23
EPS (Basic)
-0.21 -0.39 -0.68

J.Molner AS Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
EPS (Basic) - -0.16 -0.23 -0.28 -0.40

J.Molner AS EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

J.Molner AS's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.085-0)/1.6
=-0.68

J.Molner AS's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.641-0)/1.6
=-0.40

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


J.Molner AS  (OTSE:MOLNR) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


J.Molner AS EPS (Basic) Related Terms

Thank you for viewing the detailed overview of J.Molner AS's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


J.Molner AS (OTSE:MOLNR) Business Description

Traded in Other Exchanges
N/A
Address
Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618
J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines